Epigenetic alteration of the SOCS1 gene in hepatocellular carcinoma

Swiss Medical Weekly

Volumn 140, Issue JULY, 2010, Pages

  Chu, Pei Yi ^a   Yeh, Chung Min ^a   Hsu, Nicholas C ^b   Chang, Ya Sian ^c   Chang, Jan Gowth ^b,c   Yeh, Kun Tu ^a,b,d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Carcinogenesis; Hepatocellular carcinoma; Methylation; SOCS1

Indexed keywords

MESSENGER RNA; SUPPRESSOR OF CYTOKINE SIGNALING 1; SOCS1 PROTEIN, HUMAN; SUPPRESSOR OF CYTOKINE SIGNALING;

ARTICLE; CANCER CELL; CANCER SIZE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EPIGENETICS; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PROMOTER REGION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; CELL TRANSFORMATION; GENE EXPRESSION REGULATION; GENETIC EPIGENESIS; GENETICS; LIVER; LIVER TUMOR; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TAIWAN;

CARCINOMA, HEPATOCELLULAR; CELL TRANSFORMATION, NEOPLASTIC; CPG ISLANDS; DNA METHYLATION; DOWN-REGULATION; EPIGENESIS, GENETIC; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER NEOPLASMS; PROMOTER REGIONS, GENETIC; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS; TAIWAN;

EID: 84855451663     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2010.13065     Document Type: Article

References (29)

1. Caldwell S, Park SH. The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology. J Gastroenterol. 2009;44(Suppl 19):96-101.
2. Marcellin P. Hepatitis B and hepatitis C in 2009. Liver Int. 2009;29(Suppl 1):1-8.
3. Schuppan D, Afdhal NH. Liver cirrhosis. Lancet. 2008;371:838-51. (Pubitemid 351323895)
4. Krebs DL, Hilton DJ. SOCS proteins: negative regulators of cytokine signaling. Stem Cells. 2001;19:378-87. (Pubitemid 32900080)
5. Yoshimura A, Naka T, Kubo M. SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol. 2007;7:454-65. (Pubitemid 46834848)
6. Larsen L, Ropke C. Suppressors of cytokine signalling: SOCS. APMIS. 2002;110:833-44. (Pubitemid 36177279)
7. Kubo M, Hanada T, Yoshimura A. Suppressors of cytokine signaling and immunity. Nat Immunol. 2003;4:1169-76. (Pubitemid 37540685)
8. Yandava CN, Pillari A, Drazen JM. Radiation hybrid and cytogenetic mapping of SOCS1 and SOCS2 to chromosomes 16p13 and 12q, respectively Genomics. 1999;61:108-11. (Pubitemid 29487627)
9. Yoshikawa H, Matsubara K, Qian GS, et al. SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 2001;28:29-35. (Pubitemid 32405812)
10. Cornish AL, Davey GM, Metcalf D, et al. Suppressor of cytokine signaling- 1 has IFN-gamma-independent actions in T cell homeostasis. J Immunol. 2003;170:878-86. (Pubitemid 36070541)
11. Naka T, Tsutsui H, Fujimoto M, et al. SOCS-1/SSI-1-deficient NKT cells participate in severe hepatitis through dysregulated cross-talk inhibition of IFN-gamma and IL-4 signaling in vivo. Immunity. 2001;14:535-45. (Pubitemid 32520865)
12. Croker BA, Kiu H, Nicholson SE. SOCS regulation of the JAK/STAT signalling pathway. Semin Cell Dev Biol. 2008;19:414-22.
13. He B, You L, Uematsu K, et al. SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer. Proc Natl Acad Sci. USA 2003;100:14133-8. (Pubitemid 37499203)
14. He B, You L, Xu Z, et al. Activity of the suppressor of cytokine signaling- 3 promoter in human non-small-cell lung cancer. Clin Lung Cancer. 2004;5:366-70. (Pubitemid 39004334)
15. Weber A, Hengge UR, Bardenheuer W, et al. SOCS-3 is frequently methylated in head and neck squamous cell carcinoma and its precursor lesions and causes growth inhibition. Oncogene. 2005;24:6699-708. (Pubitemid 41486800)
16. Chan TF, Su TH, Yeh KT, et al. Mutational, epigenetic and expressional analyses of caveolin-1 gene in cervical cancers. Int J Oncol. 2003;23:599-604.
17. Liu TC, Lin SF, Chang JG, et al. Epigenetic alteration of the SOCS1 gene in chronic myeloid leukaemia. Br J Haematol. 2003;123:654-61.
18. Yeh KT, Yang MY, Liu TC, et al. Abnormal expression of period 1 (PER1) in endometrial carcinoma. J Pathol. 2005;206:111-20.
19. Constantinescu SN, Girardot M, Pecquet C. Mining for JAK-STAT mutations in cancer. Trends Biochem Sci. 2008;33:122-31.
20. Dimitriou ID, Clemenza L, Scotter AJ, et al. Putting out the fire: coordinated suppression of the innate and adaptive immune systems by SOCS1 and SOCS3 proteins. Immunol Rev. 2008;224:265-83.
21. Ko E, Kim SJ, Joh JW, et al. CpG island hypermethylation of SOCS-1 gene is inversely associated with HBV infection in hepatocellular carcinoma. Cancer Lett. 2008;271:240-50.
22. Miyoshi H, Fujie H, Moriya K, et al. Methylation status of suppressor of cytokine signaling-1 gene in hepatocellular carcinoma. J Gastroenterol. 2004;39:563-9. (Pubitemid 38996899)
23. Nomoto S, Kinoshita T, Kato K, et al. Hypermethylation of multiple genes as clonal markers in multicentric hepatocellular carcinoma. Br J Cancer. 2007;97:1260-5. (Pubitemid 350035807)
24. Okochi O, Hibi K, Sakai M, et al. Methylation-mediated silencing of SOCS-1 gene in hepatocellular carcinoma derived from cirrhosis. Clin Cancer Res. 2003;9:5295-8. (Pubitemid 37413582)
25. Markiewski MM, DeAngelis RA, Strey CW, et al. The regulation of liver cell survival by complement. J Immunol. 2009;182:5412-8.
26. Gotohda N, Iwagaki H, Ozaki M, et al. Deficient response of IL-6 impaired liver regeneration after hepatectomy in patients with viral hepatitis. Hepatogastroenterology. 2008;55:1439-44.
27. Yang YY, Lee KC, Huang YT, et al. Inhibition of hepatic tumour necrosis factor-alpha attenuates the anandamide-induced vasoconstrictive response in cirrhotic rat livers. Liver Int. 2009;29:678-85.
28. Schutte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma -epidemiological trends and risk factors. Dig Dis. 2009;27:80-92.
29. Yeh SH, Chen PJ, Shau WY, et al. Chromosomal allelic imbalance evolving from liver cirrhosis to hepatocellular carcinoma. Gastroenterology. 2001;121:699-709.